These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6345408)

  • 1. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New micro-glass-tube leukocyte adherence inhibition assay assessing cell adherence of mononuclear cell subpopulations defined by monoclonal antibodies.
    Morizane T; Satoh I; Kumagai N; Saito H; Iino A; Inagaki Y; Watanabe T; Tsuchimoto K; Tsuchiya M
    J Immunol Methods; 1986 Jul; 91(2):225-9. PubMed ID: 3090150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated micro-monocyte adherence inhibition assay: a new technique of leukocyte adherence inhibition to detect tumor immunity in patients with hepatoma.
    Kumagai N; Morizane T; Inagaki Y; Nakamura T; Tsuchimoto K; Watanabe T; Tsuchiya M
    Gan; 1984 Nov; 75(11):1017-24. PubMed ID: 6097491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
    Moskaug JO; Kotlar HK; Sanner T
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-leukocyte adherence inhibition. I. Cellular basis of the mechanism of reactivity.
    Russo AJ; Howell JH; Leveson SH; Holyoke ED; Goldrosen MH
    J Immunol; 1978 Nov; 121(5):1914-9. PubMed ID: 81856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.